Impact of COVID-19 on a paediatric emergency service

Rafaela Paiva1, Cátia Martins2, Fernanda Rodrigues3,2

  • 1Faculdade de Medicina da Universidade de Coimbra, Faculty of Medicine of the University of Coimbra, Coimbra, Portugal. rafaelapaiva5@gmail.com.

Insights

The COVID-19 pandemic reduced pediatric emergency visits by 60%, with fewer urgent cases but more non-urgent accidents. Referrals increased, and hospitalizations rose despite low SARS-CoV-2 infection rates in children.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Disease Epidemiology
  • Public Health Policy

Background:

  • The COVID-19 pandemic drastically altered healthcare utilization globally, impacting emergency service admissions.
  • Paediatric populations experienced significant changes in emergency service use during the pandemic.

Purpose of the Study:

  • To analyze changes in the activity of a Paediatric Emergency Service (PES) during the COVID-19 pandemic.
  • To compare paediatric emergency visit data during the pandemic with pre-pandemic periods.

Main Methods:

  • Retrospective cohort study analyzing PES visits from March 30 to June 30, 2020.
  • Comparison with data from the same period in 2017-2019.
  • Analysis of 53,883 patient episodes.

Main Results:

  • A 60% reduction in paediatric emergency admissions was observed in 2020 compared to previous years.
  • Referrals from the National Health Service (NHS) phone line and Emergency Medical Services (EMS) significantly increased.
  • There was a decrease in urgent cases and school/sports accidents, but an increase in non-urgent accidents (falls, wounds, burns, dog bites).
  • The hospitalisation rate increased, while the SARS-CoV-2 infection rate among paediatric patients was low (1.1%) with mild or asymptomatic illness.

Conclusions:

  • The pandemic led to fewer emergency admissions and urgent paediatric cases, but a rise in non-urgent accidents.
  • Increased reliance on NHS and EMS phone lines was noted, alongside a higher overall hospitalisation rate.
  • Despite low SARS-CoV-2 infection rates in children, changes in emergency service utilization patterns persisted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
75
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
100